Biblio print

Tree Display

AceDB Schema

XML Display


Author Report for: Johnson DE

No contact information in database for Johnson DE

    Title: An update on potential pharmacotherapies for cognitive impairment in bipolar disorder
    Johnson DE, McIntyre RS, Mansur RB, Rosenblat JD
    Ref: Expert Opin Pharmacother, :1, 2023 : PubMed


    Title: A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonists
    Lowe JA, 3rd, DeNinno SL, Coe JW, Zhang L, Mente S, Hurst RS, Mather RJ, Ward KM, Shrikhande A and McDowell LL <13 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 20:4749, 2010 : PubMed


    Title: Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition
    Rollema H, Hajos M, Seymour PA, Kozak R, Majchrzak MJ, Guanowsky V, Horner WE, Chapin DS, Hoffmann WE and Williams KE <3 more author(s)>
    Ref: Biochemical Pharmacology, 78:813, 2009 : PubMed


    Title: The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release
    Johnson DE, Nedza FM, Spracklin DK, Ward KM, Schmidt AW, Iredale PA, Godek DM, Rollema H
    Ref: European Journal of Pharmacology, 506:209, 2005 : PubMed


    Title: Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chloropyrifos
    Johnson DE, Seidler FJ, Slotkin TA
    Ref: Brain Research Bulletin, 45:143, 1998 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer